DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson’s disease, and progressive supranuclear palsy: A cross-comparative investigation

Megha Murthy,Katherine Fodder,Yasuo Miki,Naiomi Rambarack,Eduardo De Pablo Fernandez,Jonathan Mill,Thomas T Warner,Tammaryn Lashley,Conceição Bettencourt

DOI: https://doi.org/10.1101/2024.01.10.574852

2024-01-11

Abstract:Multiple system atrophy (MSA) is a rare neurodegenerative disease characterized by neuronal loss and gliosis, with oligodendroglial cytoplasmic inclusions (GCI’s) containing α-synuclein being the primary pathological hallmark. Clinical presentations of MSA overlap with other parkinsonian disorders such as Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and progressive supranuclear palsy (PSP), posing challenges in early diagnosis. Numerous studies have reported perturbations in DNA methylation in neurodegenerative diseases, with candidate loci being identified in various parkinsonian disorders including MSA, PD, and PSP. Although MSA and PSP present with substantial white matter pathology, alterations in white matter have also been reported in PD. However, studies comparing the DNA methylation architectures of white matter in these diseases are lacking. We therefore aimed to investigate three parkinsonian diseases, MSA, PD, and PSP, to identify shared and disease-specific DNA methylation alterations in white matter. Genome-wide DNA methylation profiling of frontal lobe white matter of individuals with MSA (n=17), PD (n=17), and PSP (n=16) and controls (n=15), using the Illumina EPIC array, revealed substantial commonalities in DNA methylation perturbations in MSA, PD, and PSP. We further used weighted gene correlation network analysis to identify disease-associated co-methylation signatures and identified dysregulation in processes relating to Wnt signalling, signal transduction, endoplasmic reticulum stress, mitochondrial processes, RNA interference, and endosomal transport. Our results highlight several shared DNA methylation perturbations and pathways indicative of converging molecular mechanisms contributing towards neurodegeneration in the white matter of all three parkinsonian diseases.

Neuroscience

What problem does this paper attempt to address?

The paper aims to address the issue of DNA methylation patterns in three Parkinsonian syndromes: Multiple System Atrophy (MSA), Parkinson's Disease (PD), and Progressive Supranuclear Palsy (PSP). Specifically, the main objective of the study is to identify shared and specific DNA methylation changes in the frontal white matter of these diseases and to uncover the molecular mechanisms leading to neurodegeneration. Through comparative analysis, the research hopes to discover common DNA methylation changes in the white matter of these diseases and their associated signaling pathways, thereby better understanding the commonalities and differences between these diseases. Additionally, the study focuses on the mechanisms of dysfunction or protein aggregation susceptibility in specific cell types, particularly oligodendrocytes, in different diseases.